Logo image of CRB.CA

CARIBOO ROSE RESOURCES LTD (CRB.CA) Stock Fundamental Analysis

Canada - TSX Venture Exchange - TSX-V:CRB - CA1420241087 - Common Stock

0.05 CAD
0 (0%)
Last: 12/31/2025, 7:00:00 PM
Fundamental Rating

2

CRB gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 804 industry peers in the Metals & Mining industry. CRB has a great financial health rating, but its profitability evaluates not so good. CRB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CRB has reported negative net income.
CRB had a negative operating cash flow in the past year.
CRB had negative earnings in each of the past 5 years.
CRB had a negative operating cash flow in each of the past 5 years.
CRB.CA Yearly Net Income VS EBIT VS OCF VS FCFCRB.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500K -500K 1M -1M

1.2 Ratios

The Return On Assets of CRB (-27.34%) is comparable to the rest of the industry.
The Return On Equity of CRB (-29.08%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -27.34%
ROE -29.08%
ROIC N/A
ROA(3y)-19.17%
ROA(5y)-15.19%
ROE(3y)-21.3%
ROE(5y)-16.8%
ROIC(3y)N/A
ROIC(5y)N/A
CRB.CA Yearly ROA, ROE, ROICCRB.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CRB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CRB.CA Yearly Profit, Operating, Gross MarginsCRB.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

7

2. Health

2.1 Basic Checks

The number of shares outstanding for CRB has been increased compared to 1 year ago.
The number of shares outstanding for CRB has been increased compared to 5 years ago.
The debt/assets ratio for CRB has been reduced compared to a year ago.
CRB.CA Yearly Shares OutstandingCRB.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
CRB.CA Yearly Total Debt VS Total AssetsCRB.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M 2M 2.5M

2.2 Solvency

CRB has an Altman-Z score of 16.51. This indicates that CRB is financially healthy and has little risk of bankruptcy at the moment.
CRB has a better Altman-Z score (16.51) than 71.89% of its industry peers.
CRB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 16.51
ROIC/WACCN/A
WACCN/A
CRB.CA Yearly LT Debt VS Equity VS FCFCRB.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1M -1M 2M

2.3 Liquidity

A Current Ratio of 2.56 indicates that CRB has no problem at all paying its short term obligations.
The Current ratio of CRB (2.56) is comparable to the rest of the industry.
A Quick Ratio of 2.56 indicates that CRB has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.56, CRB is in line with its industry, outperforming 59.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.56
Quick Ratio 2.56
CRB.CA Yearly Current Assets VS Current LiabilitesCRB.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M

More info and screens

0

3. Growth

3.1 Past

CRB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -33.90%.
EPS 1Y (TTM)-33.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CRB. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CRB.CA Price Earnings VS Forward Price EarningsCRB.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CRB.CA Per share dataCRB.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 0.02

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CRB!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

CARIBOO ROSE RESOURCES LTD

TSX-V:CRB (12/31/2025, 7:00:00 PM)

0.05

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners7.17%
Ins Owner ChangeN/A
Market Cap2.90M
Revenue(TTM)N/A
Net Income(TTM)-435.70K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.94
P/tB 1.94
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -27.34%
ROE -29.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-19.17%
ROA(5y)-15.19%
ROE(3y)-21.3%
ROE(5y)-16.8%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 233.33%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.56
Quick Ratio 2.56
Altman-Z 16.51
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)560.01%
Cap/Depr(5y)767.93%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-23.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y48.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-24.98%
OCF growth 3YN/A
OCF growth 5YN/A

CARIBOO ROSE RESOURCES LTD / CRB.CA FAQ

What is the fundamental rating for CRB stock?

ChartMill assigns a fundamental rating of 2 / 10 to CRB.CA.


What is the valuation status of CARIBOO ROSE RESOURCES LTD (CRB.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to CARIBOO ROSE RESOURCES LTD (CRB.CA). This can be considered as Overvalued.


How profitable is CARIBOO ROSE RESOURCES LTD (CRB.CA) stock?

CARIBOO ROSE RESOURCES LTD (CRB.CA) has a profitability rating of 1 / 10.